Investor Update Presentation
Investor Update Presentation
Sydney, Oct 12, 2018 AEST (ABN Newswire) - The Hydroponics Company Ltd (ASX:THC) (OTCMKTS:HDRPF) provides the Company's latest Investor Update Presentation.

Overview

- 'Farm-to-Pharma' vertical integration

- Full-scale cannabis growing facility and combined growing and R&D facility

- Pharmaceutical GMP-ready bio-pharmaceutical manufacturing facility

- Toll manufacturing capability

- Testing and product development laboratory

- Products available to Australian patients

- Established international distribution and strategic partnerships

- Revenue generating Canadian hydroponics equipment and accessory wholesaler

- Expanding global cannabis footprint across Europe as well as Canada and New Zealand

To view the full presentation, please visit:
http://abnnewswire.net/lnk/1GT64913


About The Hydroponics Company Ltd

Hydroponics Company Ltd (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) has rapidly grown to become Australia's leading medicinal cannabis company. THC operates under a pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through the existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility, THC is in prime position to service both domestic patients and the export market. THC's global commercial partners operate across four continents, supporting THC's future international growth. THC also operates a revenue generating Canadian hydroponics business, focussing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients.

    


Contact

Ken Charteris
Chief Executive Officer
The Hydroponics Company Limited
P: +61-2-9251-7177
E: ken.charteris@thcl.com.au



Related Companies

The Hydroponics Company Ltd

ABN Newswire This Page Viewed:  (Since Published: 758) 
ANALYTICS: LOGIN HERE

The Hydroponics Company Ltd NEWS: RECENT VISITS (4213)